Daniel Bischoff

3.0k total citations
51 papers, 2.4k citations indexed

About

Daniel Bischoff is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Daniel Bischoff has authored 51 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 16 papers in Organic Chemistry and 16 papers in Pharmacology. Recurrent topics in Daniel Bischoff's work include Microbial Natural Products and Biosynthesis (16 papers), Carbohydrate Chemistry and Synthesis (13 papers) and Enzyme Structure and Function (8 papers). Daniel Bischoff is often cited by papers focused on Microbial Natural Products and Biosynthesis (16 papers), Carbohydrate Chemistry and Synthesis (13 papers) and Enzyme Structure and Function (8 papers). Daniel Bischoff collaborates with scholars based in Germany, France and United States. Daniel Bischoff's co-authors include Roderich D. Süßmuth, Bojan Bister, Wolfgang Wohlleben, Graeme Nicholson, Stefan Pelzer, Günther Jung, Sigrid Stockert, Andreas Reicke, Hans‐Peter Fiedler and Alan T. Bull and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Daniel Bischoff

48 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Bischoff Germany 27 1.3k 1.2k 617 399 319 51 2.4k
Bojan Bister Germany 20 884 0.7× 955 0.8× 537 0.9× 384 1.0× 86 0.3× 26 1.8k
Cedric J. Pearce United States 33 1.9k 1.5× 1.7k 1.4× 590 1.0× 530 1.3× 141 0.4× 132 4.1k
Brian O. Bachmann United States 33 2.3k 1.8× 1.6k 1.3× 706 1.1× 516 1.3× 139 0.4× 82 3.4k
Seth B. Herzon United States 39 1.5k 1.2× 716 0.6× 2.7k 4.3× 358 0.9× 79 0.2× 118 4.1k
Ken‐ichi Kawai Japan 30 1.3k 1.0× 1.6k 1.3× 1.0k 1.6× 687 1.7× 135 0.4× 228 3.6k
Christopher N. Boddy Canada 31 2.3k 1.8× 1.4k 1.2× 1.9k 3.1× 458 1.1× 178 0.6× 95 3.9k
Jiahai Zhou China 31 2.2k 1.7× 504 0.4× 516 0.8× 284 0.7× 94 0.3× 104 3.3k
Koen H. G. Verschueren Belgium 14 2.3k 1.8× 235 0.2× 198 0.3× 220 0.6× 142 0.4× 23 3.3k
Chambers C. Hughes United States 28 848 0.7× 667 0.5× 1.3k 2.1× 473 1.2× 136 0.4× 57 2.4k
Lin Du China 30 1.1k 0.8× 1.1k 0.9× 502 0.8× 694 1.7× 42 0.1× 101 2.6k

Countries citing papers authored by Daniel Bischoff

Since Specialization
Citations

This map shows the geographic impact of Daniel Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bischoff more than expected).

Fields of papers citing papers by Daniel Bischoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bischoff. The network helps show where Daniel Bischoff may publish in the future.

Co-authorship network of co-authors of Daniel Bischoff

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Bischoff. A scholar is included among the top collaborators of Daniel Bischoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Bischoff. Daniel Bischoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bischoff, Daniel, et al.. (2025). Rational Introduction of Electrostatic Interactions at Crystal Contacts to Enhance Protein Crystallization of an Ene Reductase. Biomolecules. 15(4). 467–467. 1 indexed citations
2.
3.
Bischoff, Daniel, et al.. (2023). Recent Advances in the Monitoring of Protein Crystallization Processes in Downstream Processing. Crystals. 13(5). 773–773. 7 indexed citations
4.
Hermann, Johannes C., Daniel Bischoff, Robert Janowski, et al.. (2021). Controlling Protein Crystallization by Free Energy Guided Design of Interactions at Crystal Contacts. Crystals. 11(6). 588–588. 7 indexed citations
5.
Winter, Martin, Robert Ries, Markus Zeeb, et al.. (2020). MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein–Ligand Interactions at High Throughput. SLAS DISCOVERY. 26(1). 44–57. 18 indexed citations
6.
Winter, Martin, Robert Ries, Gisela Schnapp, et al.. (2019). MALDI-TOF Mass Spectrometry-Based High-Throughput Screening for Inhibitors of the Cytosolic DNA Sensor cGAS. SLAS DISCOVERY. 25(4). 372–383. 34 indexed citations
7.
Winter, Martin, Tom Bretschneider, Robert Ries, et al.. (2019). Chemical Derivatization Enables MALDI-TOF-Based High-Throughput Screening for Microbial Trimethylamine (TMA)-Lyase Inhibitors. SLAS DISCOVERY. 24(7). 766–777. 15 indexed citations
8.
Bretschneider, Tom, et al.. (2019). RapidFire BLAZE-Mode Is Boosting ESI-MS Toward High-Throughput-Screening. SLAS TECHNOLOGY. 24(4). 386–393. 47 indexed citations
9.
Winter, Martin, Tom Bretschneider, Robert Ries, et al.. (2018). Establishing MALDI-TOF as Versatile Drug Discovery Readout to Dissect the PTP1B Enzymatic Reaction. SLAS DISCOVERY. 23(6). 561–573. 31 indexed citations
10.
Heilker, Ralf, Uta Lessel, & Daniel Bischoff. (2018). The power of combining phenotypic and target-focused drug discovery. Drug Discovery Today. 24(2). 526–532. 23 indexed citations
11.
12.
Yu, Hongbin, Daniel Bischoff, & Donald Tweedie. (2010). Challenges and solutions to metabolites in safety testing: impact of the International Conference on Harmonization M3(R2) guidance. Expert Opinion on Drug Metabolism & Toxicology. 6(12). 1539–1549. 20 indexed citations
13.
Stegmann, Evi, Daniel Bischoff, Stefan Pelzer, et al.. (2006). Precursor-Directed Biosynthesis for the Generation of Novel Glycopetides. PubMed. 215–232. 8 indexed citations
14.
Bischoff, Daniel, Bojan Bister, Efthimia Stegmann, et al.. (2005). The Biosynthesis of Vancomycin‐Type Glycopeptide Antibiotics—A Model for Oxidative Side‐Chain Cross‐Linking by Oxygenases Coupled to the Action of Peptide Synthetases. ChemBioChem. 6(2). 267–272. 96 indexed citations
15.
Jiang, Zhengjin, Jingwu Kang, Daniel Bischoff, et al.. (2004). Evaluation of balhimycin as a chiral selector for enantioresolution by capillary electrophoresis. Electrophoresis. 25(16). 2687–2692. 23 indexed citations
16.
Bister, Bojan, Daniel Bischoff, Graeme Nicholson, et al.. (2003). Bromobalhimycin and Chlorobromobalhimycins—Illuminating the Potential of Halogenases in Glycopeptide Antibiotic Biosyntheses. ChemBioChem. 4(7). 658–662. 57 indexed citations
17.
Weist, Stefan, Bojan Bister, Oliver Puk, et al.. (2002). Fluorobalhimycin—A New Chapter in Glycopeptide Antibiotic Research. Angewandte Chemie International Edition. 41(18). 3383–3385. 73 indexed citations
18.
Zerbe, Katja, Olena Pylypenko, Francesca Vitali, et al.. (2002). Crystal Structure of OxyB, a Cytochrome P450 Implicated in an Oxidative Phenol Coupling Reaction during Vancomycin Biosynthesis. Journal of Biological Chemistry. 277(49). 47476–47485. 134 indexed citations
19.
Bischoff, Daniel, Stefan Pelzer, Alexandra Höltzel, et al.. (2001). The Biosynthesis of Vancomycin-Type Glycopeptide Antibiotics—New Insights into the Cyclization Steps. Angewandte Chemie International Edition. 40(9). 1693–1696. 107 indexed citations
20.
Bischoff, Daniel, Stefan Pelzer, Bojan Bister, et al.. (2001). The Biosynthesis of Vancomycin-Type Glycopeptide Antibiotics-The Order of the Cyclization Steps. Angewandte Chemie International Edition. 40(24). 4688–4691. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bojan Bister Breakdown of academic impact, for papers by Cedric J. Pearce Breakdown of academic impact, for papers by Brian O. Bachmann Breakdown of academic impact, for papers by Seth B. Herzon Breakdown of academic impact, for papers by Ken‐ichi Kawai Breakdown of academic impact, for papers by Christopher N. Boddy Breakdown of academic impact, for papers by Jiahai Zhou Breakdown of academic impact, for papers by Koen H. G. Verschueren Breakdown of academic impact, for papers by Chambers C. Hughes Breakdown of academic impact, for papers by Lin Du
Rankless by CCL
2026